Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $44.8000 (-1.97%) ($44.6000 - $46.5500) on Mon. Oct. 19, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.06% (three month average) | RSI | 71 | Latest Price | $44.8000(-1.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) PEJ(7%) VT(7%) XLF(7%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.03% in a week (0% probabilities). VIXM(-5%) TLT(-5%) SHY(-3%) GLD(-3%) BND(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.03% (StdDev 4.06%) | Hourly BBV | 0 () | Intraday Trend | -2.8% | | | |
|
5 Day Moving Average | $45.14(-0.75%) | 10 Day Moving Average | $44.67(0.29%) | 20 Day Moving Average | $43.64(2.66%) | To recent high | -10.4% | To recent low | 16.1% | Market Cap | $882m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |